Abstract
abbreviated new drug application Application for marketing authorisation if a drug has already received approval under a previous conventional NDA; important drug properties as e.g. toxicity and safety have therefore already been documented; see also abriged application, approval, accelerated approval program.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Wien
About this chapter
Cite this chapter
Nahler, G. (2013). A. In: Dictionary of Pharmaceutical Medicine. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1523-7_1
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1523-7_1
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1522-0
Online ISBN: 978-3-7091-1523-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)